Orthopedics Medical News about Pharmacogenomics

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Benefits of Pharmacogenomics in Drug Development-Earlier Launch of Drugs and Less Adverse Events
The Journal of Medical Systems, 04/16/09

Ohashi W et al. - PGx enables earlier launch of a drug with less cost, representing benefit to pharmaceutical companies, patients and public as a whole. Currently, pharmaceutical companies are reluctant to introduce pharmacogenomics (PGx) in their practice, since cost–benefit of PGx is obscure and methodology to use PGx in drug development has not been fully established yet.

<< Previous
Does Physical Therapy Improve Outcome in Infants With Joint...

Next >>
Adherence, compliance key with underinsured

Pharmacogenomic perspectives on the management of mood disorders
Psychiatric Bulletin, 10/02/09 Relevance Score: 87%

Pharmacogenomic variations in treatment protocols for childhood acute lymphoblastic leukemia
Pediatric Blood & Cancer, 10/02/09 Relevance Score: 83%

Role of gut microbiota in Crohns disease
Expert Review of Gastroenterology & Hepatology, 10/13/09 Relevance Score: 80%

Lack of Correlation Between Thiazide-Induced Hyperglycemia and Hypokalemia: Subgroup Analysis of Results from the Pharmacogenomic Evaluation of Antihypertensive Responses Study
Pharmacotherapy, 10/07/09 Relevance Score: 80%

Pharmacogenomics: Personalizing Drug Therapy
American Journal of Nursing, 10/01/09 Relevance Score: 80%